SCOPE | Provider Update
January 2026
Clinical Matters
January is Alcohol Awareness Month: treatment options include medications and therapy
It's important to screen for Alcohol Use Disorder during the winter months.
Healthcare providers play an important role in identifying Alcohol Use Disorder (AUD), delivering appropriate care, and connecting patients to local resources and support groups. Routine screening for AUD is essential. Screening is especially important during winter months, when reduced daylight, Seasonal Affective Disorder (SAD), and social isolation may increase alcohol usage.
The recommended screening tools include:
- AUDIT-C
- AUDIT-10
- CAGE questionnaire
- CIWA-Ar for withdrawal risk evaluation.
Certain populations are at higher risk for developing or worsening AUD. These include individuals with depression, anxiety, Post Traumatic Stress Disorder (PTSD), and chronic pain, as well as adults experiencing unemployment or homelessness, as psychosocial factors play an important role in a person’s alcohol usage and willingness and ability to quit. Older adults are also vulnerable due to dangerous interactions between alcohol and common medications such as opioids, benzodiazepines, and anticholinergics, which may cause increased sedation.
Treating AUD
Fewer than one in ten individuals with AUD receive any formal treatment. Educating patients about AUD as a chronic medical condition can reduce the stigma surrounding it and improve patient/caregiver engagement.
Pharmacologic treatment options endorsed by the American Psychiatric Association include the following:
- Naltrexone: can reduce cravings and heavy drinking but is contraindicated in patients using opioids or with advanced liver dysfunction – both common comorbidities with alcohol usage.
- Acamprosate: preferred in patients with significant liver disease because it is renally cleared and well tolerated.
- Disulfiram: does require more adherence, and it cannot be used in patients with a sulfa allergy.
It is also important to distinguish that, based on evidence from the COMBINE trial, pharmacologic management is not enough of a treatment for AUD. Typically, the patient will most likely benefit from a combination of Cognitive Behavioral Therapy (CBT), specifically in a group setting, along with pharmacologic treatment.
Linking patients to local addiction treatment services is crucial for supporting their recovery. The following community resources are available:
- Horizon Health Services offers outpatient counseling, residential rehabilitation, psychiatric care, and medication-assisted treatment.
- Erie County Medical Center provides inpatient detoxification and comprehensive outpatient programs.
- Best-Self Behavioral Health integrates mental health and substance use treatment and offers walk-in access.
- The Buffalo VA Medical Center provides specialized AUD care for eligible veterans.
Community-based resources such as St. John’s Grace, First Trinity Lutheran Church, Faith United Presbyterian Church, and Thankful Heart are all viable community resources that are easily accessible with low barriers of entry that can be found on the AA Buffalo website.
It is important to be reminded that AUD is treatable and that early recognition saves lives. By incorporating routine screening, offering evidence-based counseling and medication options, and connecting patients and caregivers with community resources, providers can meaningfully reduce the morbidity and mortality associated with alcohol use disorder.
References:
- Weiss, R. D., O’malley, S. S., Hosking, J. D., LoCastro, J. S., & Swift, R. (2008). Do patients with alcohol dependence respond to placebo? results from the combine study. Journal of Studies on Alcohol and Drugs, 69(6), 878–884.
- UpToDate: Alcohol Use Disorder, Pharmacologic Management, 2025.
- Buffalo, B. (2025). Buffalo Area AA Central office. Buffalo area AA central office.
- Reus, V., Fochtmann, L., & Bukstein, O. (2018). The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder. https://doi.org/10.1176/appi.books.9781615371969
Recommendations for cervical cancer screening
USPSTF screening schedules for cervical cancer begin at age 21
The best way to find cervical cancer early is to discuss regular screening tests. Regular screening has been shown to prevent cervical cancers and save lives. Early detection greatly improves the chances of successful treatment and can prevent any early cervical cell changes from becoming cancer.
A Pap test can find precancer cells of the cervix before they become cancer. Regular Pap tests gives patients a better chance of preventing cancer. In fact, most cases of cervical cancer are found in women who haven't had regular or any screening tests.
The American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF) notes that all women at average risk should get regular Pap tests starting at age 21. These recommendations also say that:
- Starting at age 21 until age 29, women are recommended to have a Pap test (cytology test) alone every 3 years.
- Women between ages 30 and 65 are recommended to have an HPV test alone every 5 years. Or they may have a combination HPV and Pap test (called co-test) done every 5 years. Or they may have a Pap test alone every 3 years.
- Women older than 65 who have had regular screening with normal results can stop screening for cervical cancer.
View additional information about screening tests on the American Cancer Society website.
Office Matters
2026 Provider Reimbursement Manual Updates
Yearly reminder to check the updated reimbursement manual for coding and billing changes for the coming year.
Independent Health encourages all providers to review the Participating Provider Reimbursement Manual on your provider portal, which will contain highlights of coding and billing changes for 2026. The updated manual will be posted no later than December 31, 2025.
As a reminder, Independent Health adheres to the Centers for Medicare and Medicaid Services (CMS) billing and reimbursement guidelines unless otherwise documented.
Since coding updates take place at a national level, we encourage all providers to familiarize themselves with industry standard resources and projected impacts of these changes to your practice.
These resources are also linked directly into the Participating Provider Reimbursement Manual on your provider portal.
For additional details on the new and revised codes, please review the 2026 CPT® and HCPCS books for comprehensive changes. To ensure compliance and accurate claims processing please verify the appropriate staff in your office are registered for the provider portal and are staying current with policies as well as the Participating Provider Reimbursement Manual.
Chiropractic network panel status update
Current chiropractic network is adequate for member needs.
In an effort to ensure our members have adequate access to care, we regularly review our provider network. Following a thorough evaluation, considering factors such as network adequacy and the needs of Independent Health’s membership, we’ve determined that our current panel of chiropractic providers is sufficient to meet member needs at this time and we will not allow any new groups to join our network.
As a result, effective February 1, 2026, we will be closing our panel to new chiropractic providers groups, until further notice. Exceptions will be considered on a case-by-case basis based on geographic network need.
Upcoming member engagement campaigns to encourage members to take greater control of their health
Flu shot, social needs self-screening, and OMW member outreach
Flu Shot Campaign
This campaign will encourage adult members to receive a flu vaccine this season. We encourage provider practices to further reinforce the importance of the flu vaccine with their patients.
- Target Population: Adult members in Commercial, State Programs, and Medicare lines of business
- Outreach method: Email and digital correspondence
- Timeframe: January 2026
Health-Related Social Needs Self Screening
This campaign will encourage members to complete a health-related social needs screening, and we will provide referral information for community resources if an area of need is identified.
- Target Population: MediSource Connect (HARP)
- Outreach Method: Telephonic campaign
- Timeframe: January through December 2026
Osteoporosis Management in Women Who Had a Fracture (OMW) Member Outreach
Independent Health’s Member Success Team will outreach telephonically to Medicare members who fall into the Osteoporosis Management in Women Who Had a Fracture (OMW) measure. The Member Success Team will contact members to provide education on the importance of getting screened for osteoporosis following a fracture and discuss options for gap closure. The option of an in-home heel ultrasound with Stall Senior Medical (SSM) will be discussed. If the member is interested, The Member Success Team will ask for consent for the member to be contacted by the SSM team and then SSM will call the member to schedule the appointment. All results will be sent to the member’s Primary Care Physician (PCP) for follow-up. The Member Success Team will also discuss other options for gap closure, depending on the member’s preference, and refer back to the member’s PCP. Each call will be individualized based on the member’s needs.
- Target population: The OMW measure focuses on females 67 to 85 years of age who had a fracture and have six months following the fracture to close the gap by having a bone density scan, filling a prescription for an osteoporosis medication, or receiving an injection for osteoporosis treatment.
- Timeframe: This outreach is on-going. Monthly, new members who fall into this measure will be called.
Pharmacy Updates
Formulary and Policy Changes
Remember to view our up-to-date policies online.
Drug Formulary Changes
Access Independent Health's drug formularies here.
Drug Policy Changes
Search for and view the most current versions of all Independent Health’s drug policies when logged in to our provider portal.
Prime Therapeutics reviews prior authorizations for select oncology and specialty drugs on Independent Health’s behalf. Log in to view Prime Therapeutics policies for the drugs it reviews.
To obtain a hard copy, please call Independent Health's Provider Relations Contact Center at (716) 631-3282 or 1-800-736-5771, Monday through Friday from 8 a.m. to 5 p.m.
Spotlight
Top Takeaways this Month
February 2026 Policy Updates: View them here (Posted as Monthly Policy Updates under the News tab in the secure portal). It is very important to review the monthly updates.